FDA Urges Device Manufacturers To Double-Check Their CAPA Systems
This article was originally published in The Silver Sheet
WITH CORRECTIVE AND PREVENTIVE ACTION CITATIONS consistently showing up in FDA-483 forms and warning letters, the agency is urging medical device manufacturers to ensure that they are complying with all of the CAPA requirements in the Quality System Regulation. FDA experts offer tips on performing adequate complaint investigations, integrating risk management into the CAPA system, and performing adequate verification and validation of a corrective action... FROM WRITING GUIDANCES TO ANSWERING INDUSTRY CALLS, a workday at FDA’s device center is never routine. Compliance Officer Cap Uldriks tells how staff ensure projects get done...
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The proposed rule from the US HHS that would require its agencies to review all regulations every 10 years could distract an incoming Biden administration from the COVID-19 pandemic and will “wreak havoc” on Medicare, a senior policy analyst for the Center on Budget and Policy Priorities says.
The US agency says in the latest update to its medical device shortages guidance doc that it’ll send enforcement missives to companies that don’t notify the agency of a “permanent discontinuance or an interruption in manufacturing” of products deemed critical during the COVID-19 pandemic.